Evidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain

This publication has 20 references indexed in Scilit:

• Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice
  Life Sciences, 1999
• Extracts of ginkgo biloba leaves inhibit monoamine oxidase
  Published by Elsevier ,1999
• Trends in Alternative Medicine Use in the United States, 1990-1997
  JAMA, 1998
• Herbal Medicinals
  Archives of internal medicine (1960), 1998
• Alternative Medicine — The Risks of Untested and Unregulated Remedies
  New England Journal of Medicine, 1998
• In Vitro Antioxidant Effect of Ginkgo biloba Extract (EGb 761) on Lipoperoxidation Induced by Hydrogen Peroxide in Erythrocytes of Behçet’s Patients
  The Japanese Journal of Pharmacology, 1997
• Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task
  General Pharmacology: The Vascular System, 1994
• Effects of standardized extracts GK501, from Ginkgo biloba L., G115 from Panax ginseng C. A. Meyer, and their combination, gincosan® (PHL‐00701), on the brain levels of biogenic monoamines and on the serum content of prolactin, growth hormone and ACTH
  Phytotherapy Research, 1993
• Ginkgo biloba
  The Lancet, 1992
• Effects of an extract of Ginkgo Biloba (EGB 761) on “learned helplessness” and other models of stress in rodents
  Pharmacology Biochemistry and Behavior, 1990